YXYonghao Xiao

Yonghao Xiao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yonghao Xiao has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Zeng-Guo Feng

    School of Materials Science and Engineering, Beijing Institute of Technology, Beijing 100081, China

    6 shared publications
  • Lin Ye

    School of Materials Science and Engineering, Beijing Institute of Technology, Beijing 100081, China

    3 shared publications
  • Ai-Ying Zhang

    Affiliation School of Materials Science and Engineering, Beijing Institute of Technology, Beijing, China

    2 shared publications
  • Han Wang

    Affiliations School of Materials Science and Engineering, Beijing Institute of Technology, Beijing, China, National Institute for Food and Drug Contro University, Beijing, China

    2 shared publications
  • Lin Ye

    Affiliation School of Materials Science and Engineering, Beijing Institute of Technology, Beijing, China

    2 shared publications
  • Xue Geng

    Affiliation School of Materials Science and Engineering, Beijing Institute of Technology, Beijing, China

    2 shared publications

Latest Publications

  • Preparation and study of non-thrombotic and biostable sulfobetaine-modified small-diameter polyurethane vascular grafts

    by Zhihua Liu, Yuting Ge, Yi Wei, Zhengjian Zhang, Yuehao Xing, Lin Ye, Zeng-Guo Feng, Jinyu Wu, Yonghao Xiao

  • Open Access

    Effect of Different Carbon-Supported Catalysts on the Thermal Decomposition of Energetic Thermoplastic Elastomers

    by Zhu Wang, Wenhao Liu, Haoyu Yu, Tianqi Li, Yunjun Luo, Yonghao Xiao

    To enhance the thermal decomposition properties of glycidyl azide polymer energetic thermoplastic elastomer (GAP-ETPE), the effects of nano-CuO supported on different carbon carriers (GO and CNT) were systematically investigated in this study. The structural characteristics and catalytic performances were comprehensively analyzed using XRD, Raman, XPS, UPS, BET, SEM, and TEM, coupled with thermal analysis techniques including TG-DSC and TG-MS. The results indicate that the catalytic performance follows the descending order of CuO/CNT > CuO/GO > CuO. Notably, CuO/CNT exhibits the optimal catalytic activity, advancing the exothermic peak temperature of the azide groups by approximately 33 °C and resulting in a more concentrated heat release process. The superior synergistic catalytic effect of CuO/CNT is attributed to the following: the three-dimensional network constructed by CNT effectively overcomes the agglomeration of CuO nanoparticles and the restacking defects typical of GO nanosheets, thereby significantly reducing the gas–solid mass transfer resistance. Simultaneously, the highly graphitized sp2 conjugated skeleton of CNT provides an exceptional electron transport capability, facilitating rapid electron migration. These findings demonstrate that the structure of carbon supports profoundly influences the synergistic catalytic effect of CuO, offering valuable insights into the design of highly efficient catalysts for energetic binders.

  • Evaluation of Remodeling and Regeneration of Electrospun PLGA@PCL/Elastin Small-Diameter Vascular Grafts In Vivo

    by Yonghao Xiao, Yuanguo Zhang, Yuehao Xing, Ming Gao, Yuting Ge, Hailei Li, Xin Wu, Lin Ye, Zeng-Guo Feng

    Bypass vascular grafting is an effective treatment for cardiovascular disease. Currently, small-diameter vascular grafts (SDVGs, inner diameter N-hydroxysuccinimide (NHS) retained the most soluble elastin content and achieved a compliance of 1.74 ± 0.62%/mmHg × 10-2, a bursting pressure of 1750 mmHg, and a tensile strength of 2.09 ± 0.51 MPa, which are mostly close to those of human saphenous vein. Subsequently, in vivo transplantation in the abdominal aorta showed that all implanted SDVGs cross-linked by EDC/NHS (PCEsEN) remained patent without aneurysm formation. Histological staining results further showed that the introduction of elastin not only promoted the degradation of SDVGs but also accelerated the formation of neointimal tissue and suppressed the calcification. Thus, PCEsEN shows promising potential to be translated into SDVGs in clinic.


  • Open Access

    Preparation and in vivo effectiveness evaluation of heparin-loaded PLGA@PCL core-shell fiber small-diameter vascular grafts

    by Yonghao Xiao, Han Wang, Yuhao Jiao, Yuehao Xing, Lin Ye, Ai-Ying Zhang, Xue Geng, Fanshan Qiu, Zengguo Feng, Hongbo Chen, et al.

    Cardiovascular disease has become the leading cause of death. It is the common goal for researchers worldwide to develop small-diameter vascular grafts (SDVGs) which could meet clinical needs. In this study, PLGA@PCL core-shell structural fibrous SDVGs was fabricated by coaxial electrospinning process, and then the surface heparinization of the vascular material was carried out after H2N-PEG-NH2 fixed on sodium hydroxide-treated electro-spun PCL tubes. Finally, the long-term patency and tissue regeneration of the grafts were evaluated in vivo through the rabbit carotid artery replacement model. The results indicate that the heparin-modified PLGA@PCL core-shell structural fibrous SDVGs achieved long-term patency and the arrangement of collagen and elastin in the neointima was similar to the native vessel in the rabbits after 9 months. After 3 months postoperatively, endothelialization was almost complete, and vascular calcification was also observed. It can be concluded that surface heparinization is a feasible modification method for in situ tissue-engineered vascular grafts, and controlling the occurrence of vascular calcification is another important issue to be solved in the development of SDVGs, and it is also the focus of our next research work.


  • Long-term observation of polycaprolactone small-diameter vascular grafts with thickened outer layer and heparinized inner layer in rabbit carotid arteries

    by Yonghao Xiao, Xin Jin, Liujun Jia, Jubo Li, Baojie Zhang, Xue Geng, Lin Ye, Ai-Ying Zhang, Yongquan Gu, Zeng-Guo Feng

    In our previous study, the pristine bilayer small-diameter in situ tissue engineered vascular grafts (pTEVGs) were electrospun from a heparinized polycaprolactone (PCL45k) as an inner layer and a non-heparinized PCL80k as an outer layer in the thickness of about 131 μm and 202 μm, respectively. However, the hydrophilic enhancement of inner layer stemmed from the heparinization accelerated the degradation of grafts leading to the early formation of arterial aneurysms in a period of 3 months, severely hindering the perennial observation of the neo-tissue regeneration, host cell infiltration and graft remodeling in those implanted pTEVGs. Herein to address this drawback, the thickness of the outer layers was increased with PCL80k to around 268 μm, while the inner layer remained unchangeable. The thickened TEVGs named as tTEVGs were evaluated in six rabbits via a carotid artery interpositional model for a period of 9 months. All the animals kept alive and the grafts remained patent until explantation except for one whose one side of arterial blood vessels was occluded after an aneurysm occurred at 6 months. Although a significant degradation was observed in the implanted grafts at 9 month, the occurrence of aneurysms was obviously delayed compared to pTEVGs. The tissue stainings indicated that the endothelial cell remodeling was substantially completed by 3 months, while the regeneration of elastin and collagen remained smaller and unevenly distributed in comparison to autologous vessels. Additionally, the proliferation of macrophages and smooth muscle cells reached the maximum by 3 months. These tTEVGs possessing a heparinized inner layer and a thickened outer layer exhibited good patency and significantly delayed onset time of aneurysms.


  • Research progress of implantation materials and its biological evaluation

    by Han Wang, Zhu Meng, Chen-Yu Zhao, Yong-Hao Xiao, Hang Zeng, Huan Lian, Rui-Qin Guan, Yu Liu, Zeng-Guo Feng, Qian-Qian Han

    With the development of modern material science, life science and medical science, implantation materials are widely employed in clinical fields. In recent years, these materials have also evolved from inert supports or functional substitutes to bioactive materials able to trigger or promote the regenerative potential of tissues. Reasonable biological evaluation of implantation materials is the premise to make sure their safe application in clinical practice. With the continual development of implantation materials and the emergence of new implantation materials, new challenges to biological evaluation have been presented. In this paper, the research progress of implantation materials, the progress of biological evaluation methods, and also the characteristics of biocompatibility evaluation for novel implantation materials, like animal-derived implantation materials, nerve contact implantation materials, nanomaterials and tissue-engineered medical products were reviewed in order to provide references for the rational biological evaluation of implantable materials.


  • Open Access

    Hydrogel Dressing Containing Basic Fibroblast Growth Factor Accelerating Chronic Wound Healing in Aged Mouse Model

    by Yonghao Xiao, Hui Zhao, Xiaoyu Ma, Zongheng Gu, Xin Wu, Liang Zhao, Lin Ye, Zengguo Feng

    Due to the decreasing self-repairing ability, elder people are easier to form chronic wounds and suffer from slow and difficult wound healing. It is desirable to develop a novel wound dressing that can accelerate chronic wound healing in elderly subjects to decrease the pain of patients and save medical resources. In this work, Heparin and basic fibroblast growth factor(bFGF) were dissolved in the mixing solution of 4-arm acrylated polyethylene glycol and dithiothreitol to form hydrogel dressing in vitro at room temperature without any catalysts, which is convenient and easy to handle in clinic application. In vitro re-lease test shows the bFGF could be continuously released for at least 7 days, whereas the dressing surface integrity maintained for 3 days degradation in PBS solution. Three groups of treatments including bFGF-Gel, bFGF-Sol and control without any treatment were applied on the full-thickness wound on the 22 months old mice back. The wound closure rate and histological and immunohistochemical staining all illustrated that bFGF-Gel displayed a better wound healing effect than the other two groups. Thus, as-prepared hydrogel dressing seems supe-rior to current clinical treatment and more effective in elderly subjects, which shows promising potential to be applied in the clinic.